
Loading, please wait...

Loading, please wait...

Modern clinical practice relies heavily on portable and implantable electronic devices. Consequently, the demand for safe, high-performance energy storage is rising. Researchers recently unveiled a breakthrough in solid-state proton batteries using graphdiyne oxide (GDYO), which could redefine how we power medical technology.
This research addresses a major hurdle in battery science: low conductivity in solid electrolytes at room temperature. Specifically, the team constructed a three-dimensional hydrogen bonding network by combining GDYO with phosphoric acid. Furthermore, this GDYO@HPO4 electrolyte facilitates efficient proton transport through a sophisticated hopping mechanism.
Safety is paramount in medical applications, especially for internal devices like pacemakers. Notably, these batteries eliminate the need for flammable liquid electrolytes. Therefore, they offer a safer alternative for patients. Moreover, the assembled full solid-state battery demonstrated an ultrahigh charge-discharge rate of 50C, retaining over 50% capacity.
Longevity is another critical factor for implantable technology. Additionally, this system showed remarkable cycling stability, maintaining 90.2% capacity even after 4500 cycles. In contrast to current lithium-ion systems, these proton-based batteries could significantly extend the lifespan of life-saving medical devices.
Ultimately, the molecular-level design of GDYO provides a robust platform for advanced electrocatalysts. This research paves the way for high-performance, long-lasting energy solutions in healthcare.
Solid-state proton batteries use hydrogen ions as charge carriers and solid electrolytes. This design is generally safer and more stable than the liquid-based lithium-ion batteries found in many current portable devices.
A high charge rate allows medical devices to recharge rapidly. This feature is essential for emergency equipment and portable diagnostics that require immediate readiness in clinical settings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of a physician or other qualified health provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Huang Y et al. Graphdiyne Oxide-Enabled Solid-State Proton Battery Exhibiting Superior Rate Capability. Angew Chem Int Ed Engl. 2026 Jun 20. doi: 10.1002/anie.4266547. PMID: 42322151.
2. ANSTO. A breakthrough in all-organic proton batteries for safer, sustainable energy storage. 2025.
3. Jiang W et al. Tumor Reoxygenation and Blood Perfusion Enhanced Photodynamic Therapy using Ultrathin Graphdiyne Oxide Nanosheets. Nano Lett. 2019.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A novel solid-state proton battery using graphdiyne oxide (GDYO) offers ultra-high charge rates and exceptional stability, paving the way for safer and more efficient medical devices.
2 months ago

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
Last week

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
4 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
4 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
Last week